A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug ...

The Food and Drug Administration approved Gilead's twice-yearly antiviral drug for preventing HIV. The company and some ...

Investing.com -- Shares of AstraZeneca (ST: AZN) and GlaxoSmithKline (LON: GSK) fell Tuesday after former U.S. President ...

During a live event, Binod Dhakal, MD, and participants discussed their experience using selinexor in the second line and ...

The global preventive healthcare technologies market, valued at $296.48 billion in 2024, is set to hit $1.19 trillion by 2034 ...

Dr. Stephana Julia Moss, an investigator at the Canadian Center for Vaccinology (CCfV), Dalhousie University, has been ...

The Government has announced a 'significant' shake-up to the childhood vaccination schedule this year. Here's what parents ...

Ticks are spreading globally and bringing familiar conditions such as Lyme disease with them, as well as totally new ones.

The chronic hepatitis B market size is predicted to surge owing to the increasing prevalence of the disease globally and ...

The stock of Sigachi Industries tanked 6.88 per cent, Shilpa Medicare dropped 4.92 per cent, Suven Life Sciences declined ...

At ASCO 2025, an expert discusses encouraging new early-phase research in clinical trials on treating myeloma.

Early intervention in high-risk smoldering myeloma with lenalidomide delays progression by up to 7 years and achieves ...